ducat pnevmatika Kritično bladder cancer cd73 metastatic marker študij Prevladujoč jed
CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer | Cell Death & Disease
Frontiers | Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint | Nature Communications
Cancers | Free Full-Text | CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors | PNAS
CD73 expression in different cancer cell lines. | Download Table
The difference of CD73 expression levels in lung cancer tumor tissue... | Download Scientific Diagram
Cancers | Free Full-Text | Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles
The elegant complexity of mammalian ecto-5′-nucleotidase (CD73): Trends in Cell Biology
Cancers | Free Full-Text | Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39 | Journal of Medicinal Chemistry
Frontiers | Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
Frontiers | CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer - ScienceDirect
Targeting CD73 to augment cancer immunotherapy - ScienceDirect
CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells - ScienceDirect
Cancers | Free Full-Text | Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
IJMS | Free Full-Text | Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
Single Cell Spatial Analysis Reveals the Topology of Immunomodulatory Purinergic Signaling in Glioblastoma | bioRxiv
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint | Nature Communications
Molecular principles of metastasis: a hallmark of cancer revisited | Signal Transduction and Targeted Therapy
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model | BMC Cancer | Full Text
CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy | Journal for ImmunoTherapy of Cancer
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39 | Journal of Medicinal Chemistry
Towards predictive biomarkers for immunotherapy response in breast cancer patients | Breast Cancer Management
Ecto‐5′‐nucleotidase (CD73) is a potential target of hepatocellular carcinoma - Shali - 2019 - Journal of Cellular Physiology - Wiley Online Library